Evidence-Based Pharmacy: Taxanes Based Antitumor Diterpenes of Taxus Baccata L. Herbal Medicinal Products for Oncology

Authors

DOI:

https://doi.org/10.53933/sspmpm.v2i1.38

Keywords:

evidence-based pharmacy, cancer, pharmacotherapy, anticancer drugs, herbal raw materials, taxanes

Abstract

Creating of new effective, safe, high-quality and cost-effective drugs for cancer patients is important for scientists. In recent years, herbal medicines have been widely used in the pharmacotherapy of cancer. The world is conducting research among substances of natural origin in terms of determining non-traditional effects on tumor growth. The aim of the study was to study medicinal phytopreparations for oncology based on taxanes, antitumor diterpenes of Taxus Baccata L. from the position of evidence-based pharmacy. Taxanes have been shown to be promising in cancer pharmacotherapy. Pharmacological studies of taxanes isolated from the "foot" of Taxus Baccata L. were described. The results of the study of potential anticancer agents based on the diterpenoid taxane skeleton have been established. It has been proven to increase the effectiveness of pharmacotherapy of operable breast cancer with the inclusion of taxanes in adjuvant and non-adjuvant chemotherapy.

Author Biography

Alina Osyntseva, Kharkiv Medical Academy of Postgraduate Education

Since 2014 I have been working as a senior lecturer at the Department of Medical and Pharmaceutical Law, General and Clinical Pharmacy of the Kharkiv Medical Academy of Postgraduate Education.

References

Shapovalova V.O., Zbrozhek S.I., Shapоvalov V.V. et al. Coronavirus disease pandemia 2019: growth of epidemic dangers. Acta scientific pharmaceutical sciences. 2020. Vol. 4. Issue 7. P. 61–68. DOI: https://doi.org/10.31080/ASPS.2020.04.0559

Shapovalov V., Butko L., Shapovalov V. Organizational and legal study of quarantine restrictions in the spread of coronavirus disease in Ukraine. SSP Modern Pharmacy and Medicine. 2021. Vol. 1. N. 2. P. 1–12. URL: https://doi.org/10.53933/sspmpm.v1i2.23. DOI: https://doi.org/10.53933/sspmpm.v1i2.23

Zbrozhek S. Reform of the healthcare system as a basis for streamlining the organization of circulation and availability of medicines for patients in the context of the COVID-19 pandemic. SSP Modern Pharmacy and Medicine. 2021. Vol. 1. No. 2. P. 1-32. URL: https://doi.org/10.53933/sspmpm.v1i2.31. DOI: https://doi.org/10.53933/sspmpm.v1i2.31

Shapovalov V. (Jr.), Zbrozhek S., Gudzenko A. et al. Organizational and legal analysis of the pharmaceutical provision for the most common diseases of society. International Journal of Pharmaceutical Sciences Review and Research. 2018. Vol. 51. N. 1. P. 118-124. URL: http://globalresearchonline.net/journalcontents/v51-1/18.pdf.

Shapovalova V.A., Zbrozhek S.I., Shapovalov V.V. et al. Forensic pharmacy: some risk factors in the formation of addictive health disorders. Acta Scientific Pharmaceutical Science. 2021. V. 4. Iss. 1. P. 7–12. DOI: 10.3180/ASPS.2020.05.0651. DOI: https://doi.org/10.31080/ASPS.2020.05.0651

Hayduchok I.G., Shapovalova V.O., Ishcheikin K.E. et al. Pharmacoeconomic approaches for pharmacotherapy of Rheumatoid arthritis. Likars’ka Sprava. 2021. N. 1–2. P. 54-63. DOI 10.31640/JVD.1-2.2021(8). DOI: https://doi.org/10.31640/JVD.1-2.2021(11)

Grytsyk А., Gnatoyko К. Characteristics of plants of the Genus eryngium and prospects of their use in medicine. SSP Modern Pharmacy and Medicine. 2021. Vol.1. N.2. P.1–8. URL:https://doi.org/10.53933/sspmpm.v1i2.27.

Derkach A., Butko A., Nehretskii S. Evidence-based pharmacy: obtaining and studying of aescine from the plant of aesculus hippocastanum. SSP Modern Pharmacy and Medicine. 2021. Vol. 1. N.1. P. 1–7. URL: https://doi.org/10.53933/sspmpm.v1i1.10. DOI: https://doi.org/10.53933/sspmpm.v1i1.10

Grytsyk A., Struk O., Stasiv T. Investigation of acute toxicity and hepaprotective effect of extracts of Nepeta cataria L. Actual Problems of Medicine and Pharmacy. 2021. Vol. 1. N. 1-2. Retrieved from https://apmplmi.com/index.php/apmp/article/view/22.

Grytsyk A., Dubel N., Grytsyk L. Research of extraction parameters of Alchemilla subcrenata bus. Herb. SSP Modern Pharmacy and Medicine. 2021. Vol.1. N.2. P. 1–9. URL: https://doi.org/10.53933/sspmpm.v1i2.28. DOI: https://doi.org/10.53933/sspmpm.v1i2.28

Invitation to the XVIII Multidisciplinary Scientific and Practical Conference with International Participation "Medical and Pharmaceutical Law of Ukraine: Organization of Pharmaceutical Business, Technology, Pharmaceutical Analysis and Pharmacology of Medicines, Forensic Pharmacy", which will be held on November 18-19, 2021 (Ukrainian registration certificate No. 403 of 24.12.2020). Lviv Medical Institute LLC. 18.01.2021. URL:https://medinstytut.lviv.ua/konferentsiya-med-i-farm-pravo/

XI Congress of Oncologists summed up its work. Oncology.ru. 21.05.2021. URL: http://www.oncology.ru/news/2021/05/21/.

Shapovalov V.V. (Jr.), Zbrozhek S.I., Shapovalova V.O. et al. Organizational and legal evaluation of availability of medicines’ circulation for cancer patients Pharmacia. 2018. Vol. 65. N. 2. P. 17-22. URL: http://bsphs.org/?magasine=organizational-and-legal-evaluation-of-availability-of-medicines-circulation-for-cancer-patients.

Oncology in Ukraine: incidence and mortality rates in 2019-2020. Analytical portal "Slovo i dilo". 14.05.2021. URL: https://ru.slovoidilo.ua/2021/05/14/infografika/obshhestvo/onkologiya-ukraine-uroven-zabolevaemosti-i-smertnosti-2019-2020-godax.

Cancer in 2020: 19.3 million new cases and 10 million deaths. UN.15.12.2020. URL: https://news.un.org/ru/story/2020/12/1392562.

National Strategy for Cancer Control until 2030. Ministry of Health of Ukraine. 12.02.2020. URL: https://moz.gov.ua/article/news/nacionalna-strategija-kontrolju-onkologichnih-zahvorjuvan-do-2030-roku.

Zbrozhek S.I., Shapovalov V.V. (Jr.), Tarasova I.V. et al. Study of the problem of availability of narcotic analgesic drugs for cancer patients on the basis of pharmaceutical law. Collection of scientific works of NMAPE named after P.L. Shupyk. 2017. Is. 28. P. 446–458.

Zbrozhek S.I., Shapovalova V.O., Shapovalov V.V. et al. Processing of the control regime of medicines for pharmacotherapy of chronic pain syndrome in the field of palliative aid. Likars'ka sprava. 2019. No 5-6. P.111-118. DOI: 10.31640/JVD.5-6. DOI: https://doi.org/10.31640/JVD.5-6.2019(15)

Zbrozhek S.I., Shapovalova V.A., Shapovalov V.V. et al. Peculiarities of pharmaceutical provision of cancer patients with analgesic drugs in various countries of the world. Pharmacy of Kazakhstan. 2017. No. 1. pp. 18–24.

Shapovalova V.O. Creation of children dosage forms on the basis of known pharmacological substances: author's ref. dis. for degree of doctor of pharmaceutical sciences. Science: special. 15.00.04 "Organization and economics of pharmacy", 15.00.01 "Technology of drugs". Kharkiv, 1996. 46 p.

The system of developing antitumor preparation in the USSR and USA / End by N.N. Blokliin (USSR) and C.G. Lubrod (USA) joint USSR-USA edition: "Meditsina". 1977. 352 p.

Blokhin N.N., Perevodchikova N.I. Chemotherapy of tumors. USSR Academy of Medical Sciences. M.: Meditsina, 1984. 304 s.

Combined and complex treatment of patients with malignant tumors. Guide for physicians / Under ed. of V.I. Chisov, M.: Medicine, 1989. 560 p.

Brogden J.M. Nevidjon B. Vinorelbine tirtrate (Navelbine): drug profile and nursing implications of a new vinca alkaloid. Oncology Nursing Forum. 1995. Vol. 22. N. 4. P. 635 -646.

Tliigpen J.T., Vance R., Puneky L. et al. Chemotherapy as a palliative treatment in carcinoma of tlie uterine cervix. Seminars in Oncology. 1995. Vol. 22. N. 2. P. 16-24.

Kawaliara М. Pliase III studies of combined chemotherapy and radiation in locally advanced non-small-cell lung cancer and limited small-cell lung cancer. Journal of Cancer & Chemotherapy. 1995. Vol. 20. N. 3. P. 335-40.

Toso С., Lindley С. Vinorelbine: a novel vinca alkaloid. American Journal of Health-System Pharmacy. 1995. Vol. 52. N. 12. P. 1287-304. DOI: https://doi.org/10.1093/ajhp/52.12.1287

Mottet Auselo N., Bons-Rosset F., Pellae-Cosset B. et al. Сarboplatin and urothelial tumors: review of the literature. Bulletin du Cancer. 1995. Vol. 82. N. 3. P. 181-188.

Huizing M. T., Misservh Pieters R. C. et. all. Taxaiu-s: a new class oil antitumor agents. Cancer Investigation. 1995. Vol. 13. N. 4. P. 381-404. DOI: https://doi.org/10.3109/07357909509031919

Bunn P. A. Ir., Kelly K. New treatment agents for advanced small cell and non-small cell lung cancer. Source Seminars in Oncology. 1995. Vol. 22. N. 3. P. 53-63.

Bitton R.J., Figg W.D., Reed E.A. Pidiminary risk-benefit assessment of paclitaxel. Drug Safety. 1995. Vol. 12. N. 3. P. 196-208. DOI: https://doi.org/10.2165/00002018-199512030-00005

Lorigan P., Lee S.M., Betticher D. et. all. Chemotherapy with vincristine fosfamide, carboplatin, etoposide in small cell lung cancer. Seminars in Oncology. 1995. Vol. 22. N. 3. P. 32-41.

Lavelle F. Bissery M.C., Combeau Z. et. all. Preclinical evaluation of docetaxel (Taxotere). Seminars in Oncology. 1995. Vol. 22. N. 2. P. 3-16.

Fossella F.V., Lee J.S., Berillc J. Summary of phase II data of docetaxel (Taxotere), an active agent in (lie list- and second-line treatment оr advanced non-small cell lung cancer. Source Seminars in Oncology. 1995. Vol. 22. N. 2. P. 22-29.

Taxus Baccata. Material from Wikipedia. URL: https://en.wikipedia.org/wiki/Taxus_baccata.

Tekol Y. The medieval physician Avicenna used an herbal calcium channel blocker, Taxus baccata L. Phytotherapy Research. 2007. Vol. 21, N. 7. P. 701–702. DOI: https://doi.org/10.1002/ptr.2173

Jasmine N., Fauzee S. Taxanes: promising anti-cancer drugs. Asian Pac. J. Cancer Prev. 2011. Vol.12. N.4. P. 837-51. URL: https://pubmed.ncbi.nlm.nih.gov/21790213/.

Roche M., Kyriakou H., Seiden M. Drug evaluation: tesetaxel--an oral semisynthetic taxane derivative. Curr Opin Investig Drugs. 2006. Vol. 7. N. 12. Р. 1092-1099. URL: https://pubmed.ncbi.nlm.nih.gov/17209527/.

Kingston G. I, Newman D. J. Taxoids: cancer-fighting compounds from nature. Curr Opin Drug Discov Devel. 2007. Vol. 10. N. 2. Р.130-144. URL: https://pubmed.ncbi.nlm.nih.gov/17436548/.

Kovalev A.A. Taxanes in chemotherapy for breast cancer. Specialized medical portal. 21.10.2017. URL:https://health-ua.com/article/31337-taksany-v-himioterapii-raka-molochnojzhelezy.

Limareva S.V. Taxanes in adjuvant and neoadjuvant therapy of breast cancer. Tumors of the female reproductive system. 2010. N. 4. P. 15-23. URL: https://doi.org/10.17650/1994-4098-2010-0-4-15-23.

Shapovalova V.O., Shapovalov V.V., Negretsky S.M. et al. Certificate of registration of copyright to the work. Ukraine. No. 107818. Textbook for undergraduate and postgraduate forms of education "Collection of test tasks". (Registration date 06.09.2021). Application c202105954 dated 25.08.2021.

Published

2022-02-04

How to Cite

Osyntseva, A., Derkach, A., & Negretskii, S. (2022). Evidence-Based Pharmacy: Taxanes Based Antitumor Diterpenes of Taxus Baccata L. Herbal Medicinal Products for Oncology. SSP Modern Pharmacy and Medicine, 2(1), 1–12. https://doi.org/10.53933/sspmpm.v2i1.38

Issue

Section

Health Sciences. Pharmacy